Great Valley Advisor Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $539K | Sell |
1,211
-10,372
| -90% | -$4.62M | 0.01% | 583 |
|
|
2025
Q1 | $5.62M | Sell |
11,583
-9,010
| -44% | -$4.37M | 0.12% | 166 |
|
|
2024
Q4 | $8.29M | Buy |
20,593
+2,343
| +13% | +$944K | 0.19% | 120 |
|
|
2024
Q3 | $8.49M | Buy |
18,250
+3,463
| +23% | +$1.61M | 0.21% | 118 |
|
|
2024
Q2 | $6.93M | Buy |
14,787
+1,968
| +15% | +$922K | 0.19% | 120 |
|
|
2024
Q1 | $5.36M | Buy |
12,819
+8,737
| +214% | +$3.65M | 0.16% | 135 |
|
|
2023
Q4 | $1.66M | Buy |
4,082
+1,883
| +86% | +$766K | 0.06% | 266 |
|
|
2023
Q3 | $764K | Buy |
2,199
+594
| +37% | +$206K | 0.03% | 360 |
|
|
2023
Q2 | $564K | Sell |
1,605
-1
| -0.1% | -$352 | 0.02% | 417 |
|
|
2023
Q1 | $506K | Sell |
1,606
-9,547
| -86% | -$3.01M | 0.02% | 434 |
|
|
2022
Q4 | $3.22M | Buy |
+11,153
| New | +$3.22M | 0.16% | 150 |
|
|
2020
Q3 | – | Sell |
-700
| Closed | -$204K | – | 454 |
|
|
2020
Q2 | $204K | Buy |
+700
| New | +$204K | 0.03% | 382 |
|